Panagora Asset Management Inc Aerie Pharmaceuticals Inc Transaction History

Panagora Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.95 - $9.16 $17,394 - $32,188	-3,514 Reduced 7.17%	45,517 $341,000
Q1 2022 May 12, 2022	BUY	$5.64 - $9.8 $276,534 - $480,503	49,031 New	49,031 $446,000
Q3 2021 Nov 10, 2021	SELL	$11.32 - $16.63 $781 - $1,147	-69 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$15.16 - $18.97 $1,046 - $1,308	69 New	69 $1,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.